# China NMPA Product Recall - Composite femoral stem

Source: https://www.globalkeysolutions.net/records/china_product_recall/zimmer-inc/d2cfd2c4-289b-4797-b780-29f29cbfca65/
Source feed: China

> China NMPA product recall for Composite femoral stem by Zimmer Inc. published July 06, 2015. Recall level: . Zimmer Inc. initiated a voluntary global recall of its Composite Femoral Stem, marketed under the tr

---

## Details

- Record Type: CHINA_PRODUCT_RECALL
- Title: Zimmer Inc. is recalling its modular femoral stem (trade name: Zimmer).
- Company Name: Zimmer Inc.
- Publication Date: 2015-07-06
- Product Name: Composite femoral stem
- Recall Reason: The inner and outer conical stem components and femoral neck component of the Kinectiv® modular femoral stem prosthesis may pose a risk exceeding cytotoxic levels.
- Discovering Company: Zimmer Medical (Shanghai) International Trading Co., Ltd.
- Manufacturing Company: Zimmer Inc.
- Summary: Zimmer Inc. initiated a voluntary global recall of its Composite Femoral Stem, marketed under the trade name Zimmer, specifically the Kinectiv


 modular femoral stem prosthesis. This action stems from a critical safety concern: a potential risk where cytotoxic levels exceeded acceptable limits within the inner and outer conical stem components and femoral neck components of the device. These components are integral to a cementless hip prosthesis used for hip replacement procedures.

The recall was formally reported to China's National Medical Products Administration (NMPA) by Zimmer (Shanghai) Medical International Trading Co., Ltd. The regulatory oversight for this product falls under the NMPA, which governs medical device registrations and recalls, as indicated by its CFDA (Imported) registration certificate number (e.g., 2012 No. 3462991).

A key detail of this recall, first reported on May 22, 2015, and published by NMPA on July 6, 2015, is that the specific affected product batches were confirmed by Zimmer Inc. as not having been sold or imported into the Chinese market. Therefore, no direct product retrieval or remedial actions were necessary for consumers within China. However, the NMPA mandated that provincial food and drug administrations enhance their general oversight of similar medical devices, reflecting a preventative regulatory measure to safeguard public health.

Company: https://www.globalkeysolutions.net/companies/zimmer-inc/05cec43c-1d05-4504-b41e-c83d04872937/